Skip to main content

Acova Disease Interactions

There is 1 disease interaction with Acova (argatroban).

Major

Thrombin inhibitors (applies to Acova) active bleeding

Major Potential Hazard, High plausibility. Applicable conditions: Coagulation Defect

The use of thrombin inhibitors is contraindicated in the presence of active major bleeding. Additionally, these drugs should be used with caution in patients with disease states associated with an increased risk of bleeding.

References

  1. "Product Information. Pradaxa (dabigatran)." Boehringer-Ingelheim (2010):
  2. "Product Information. Bivalirudin (bivalirudin)." Fresenius Kabi USA, LLC (2016):

Acova drug interactions

There are 155 drug interactions with Acova (argatroban).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer